Skip to main content
. 2019 Dec 9;27(1):1–14. doi: 10.1080/10717544.2019.1701141

Figure 6.

Figure 6.

In vivo antitumor evaluation in B16 xenografted C57 mice. (A) Tumor volume over the treatment regimen (n = 8); (B) Tumor weight at the experimental endpoint; (C) Representative tumor tissues after treatment; (D) Change in body weight over the regimen.